Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
15 p, 1024.0 KB The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study / Zijlstra, Josée M. (Amsterdam UMC) ; Follows, George (Cambridge University Hospitals NHS Foundation Trust (Regne Unit)) ; Casasnovas, Rene-Olivier (University Hospital F. Mitterrand) ; Vermaat, Joost S. P. (Leiden University Medical Center) ; Kalakonda, Nagesh (University of Liverpool) ; Choquet, Sylvain (Hôpital Pitié Salpêtrière) ; Hill, Brian (Taussig Cancer Institute) ; Thieblemont, Catherine (Saint-Louis Hospital) ; Cavallo, Federica (University of Torino/AOU) ; la Cruz, Fatima De (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Kuruvilla, John (Princess Margaret Cancer Centre) ; Hamad, Nada (University of Notre Dame Australia) ; Jaeger, Ulrich (Medical University of Vienna) ; Caimi, Paolo (Case Western Reserve University) ; Gurion, Ronit (Rabin Medical Center) ; Warzocha, Krzysztof (Instytut Hematologii I Transfuzjologii) ; Bakhshi, Sameer (All India Institute of Medical Sciences (Nova Delhi, Índia)) ; Sancho, Juan-Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Schuster, Michael (Stony Brook University Hospital) ; Egyed, Miklos (Teaching Hospital Mór Kaposi) ; Offner, Fritz (Ghent University Hospital (Bèlgica)) ; Vassilakopoulos, Theodoros P. (National and Kapodistrian University of Athens) ; Samal, Priyanka (Institute of Medical Sciences & SUM Hospital) ; Ku, Matthew (St Vincent's Hospital (Sydney)) ; Xu, Jenny (Karyopharm Therapeutics) ; Corona, Kelly (Karyopharm Therapeutics) ; Chamoun, Kamal (Karyopharm Therapeutics) ; Shah, Jatin (Karyopharm Therapeutics) ; Canales, Miguel (Hospital Universitario La Paz (Madrid)) ; Maerevoet, Marie (Institut Jules Bordet) ; Universitat Autònoma de Barcelona
Selinexor, an oral selective inhibitor of nuclear export, was evaluated in the Phase 2b SADAL study in patients with diffuse large B-cell lymphoma (DLBCL) who previously received two to five prior systemic regimens. [...]
2022 - 10.3390/cancers14030791
Cancers, Vol. 14 (february 2022)  

Vegeu també: autors amb noms similars
2 Xu, J.
1 Xu, J.F.
2 Xu, Jiake
2 Xu, Jian
1 Xu, Jianfeng
1 Xu, Jiangbing
3 Xu, Jiaolong
1 Xu, Jinbo
3 Xu, Jing
1 Xu, Jingyao
1 Xu, Jingyin
1 Xu, Jiren
1 Xu, Jun
1 Xu, Junqiang
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.